ANDA 65202, held by Ranbaxy Labs Ltd. Cefprozil.
As of Nov 13, 2026, ANDA 65202 (Cefprozil), held by Ranbaxy Labs Ltd, was first approved by FDA on Jun 30, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 30, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
